Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology
Top Cited Papers
- 1 February 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 31 (1) , 14-30
- https://doi.org/10.1097/ftd.0b013e3181957a3b
Abstract
Active and passive smoking have been associated with an array of adverse effects on health. The development of valid and accurate scales of measurement for exposures associated with health risks constitutes an active area of research. Tobacco smoke exposure still lacks an ideal method of measurement. A valid estimation of the risks associated with tobacco exposure depends on accurate measurement. However, some groups of people are more reluctant than others to disclose their smoking status and exposure to tobacco. This is particularly true for pregnant women and parents of young children, whose smoking is often regarded as socially unacceptable. For others, recall of tobacco exposure may also prove difficult. Because relying on self-report and the various biases it introduces may lead to inaccurate measures of nicotine exposure, more objective solutions have been suggested. Biomarkers constitute the most commonly used objective method of ascertaining nicotine exposure. Of those available, cotinine has gained supremacy as the biomarker of choice. Traditionally, cotinine has been measured in blood, saliva, and urine. Cotinine collection and analysis from these sources has posed some difficulties, which have motivated the search for a more consistent and reliable source of this biomarker. Hair analysis is a novel, noninvasive technique used to detect the presence of drugs and metabolites in the hair shaft. Because cotinine accumulates in hair during hair growth, it is a unique measure of long-term, cumulative exposure to tobacco smoke. Although hair analysis of cotinine holds great promise, a detailed evaluation of its potential as a biomarker of nicotine exposure, is needed. No studies have been published that address this issue. Because the levels of cotinine in the body are dependent on nicotine metabolism, which in turn is affected by factors such as age and pregnancy, the characterization of hair cotinine should be population specific. This review aims at defining the sensitivity, specificity, and clinical utilization of different methods used to estimate exposure to cigarette smoking and environmental tobacco smoke.Keywords
This publication has 141 references indexed in Scilit:
- Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methodsJournal of Pharmaceutical and Biomedical Analysis, 2004
- The Discrepancy Between Self-Reported Smoking Status and Urine Cotinine Levels Among Women Enrolled in Prenatal Care at Four Publicly Funded Clinical SitesJournal of Public Health Management & Practice, 2003
- Clinical considerations in study designs that use cotinine as a biomarkerBiomarkers, 2003
- Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studiesThe Journal of Maternal-Fetal & Neonatal Medicine, 2003
- Saliva cotinine as indicator of cigarette smoking in pregnant womenAddiction, 2001
- Variations in cotinine levels in smokers during and after pregnancyAmerican Journal of Obstetrics and Gynecology, 1998
- Respiratory Health Effects of Exposure to Environmental Tobacco SmokeReviews on Environmental Health, 1996
- The axial distribution of nicotine content along hair shaft as an indicator of changes in smoking behaviour: evaluation in a smoking‐ cessation programme with or without the aid of nicotine chewing gum.British Journal of Clinical Pharmacology, 1995
- Fetal toxicology of environmental tobacco smokeCurrent Opinion in Pediatrics, 1995
- Pharmacologic Aspects of Cigarette Smoking and Nicotine AddictionNew England Journal of Medicine, 1988